Valuation: EBOS Group Limited

Market Cap 3.63B 4.45B 2.49B 2.23B 2.06B 1.87B 3.54B 233B 24.63B 9.81B 125B 9.34B 9.14B 395B P/E 2027 *
15.5x
P/E 2028 * 13.5x
Enterprise Value 4.65B 5.7B 3.18B 2.85B 2.63B 2.39B 4.52B 298B 31.5B 12.55B 160B 11.95B 11.69B 506B EV / Sales 2027 *
0.33x
EV / Sales 2028 * 0.32x
Free-Float
90.8%
Yield 2027 *
5.36%
Yield 2028 * 5.87%
1 day+3.33%
1 week+1.93%
Current month+5.85%
1 month+14.33%
3 months-0.18%
6 months+1.45%
Current year-21.43%
1 week 20.96
Extreme 20.96
21.84
1 month 19.07
Extreme 19.07
21.84
Current year 18.45
Extreme 18.45
28.09
1 year 18.45
Extreme 18.45
29.5
3 years 18.45
Extreme 18.45
42.55
5 years 18.45
Extreme 18.45
46.75
10 years 16.05
Extreme 16.05
46.75
Manager TitleAgeSince
Chief Executive Officer 51 30/06/2025
Director of Finance/CFO - 29/09/2024
Chief Tech/Sci/R&D Officer - 04/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 30/06/2019
Director/Board Member 60 30/06/2021
Date Insider Type Main position Quantity % Market Cap. Importance
18/09/26 Buy

Director

27 0.0000%
18/09/26 Buy

Director

160 0.0001%
18/09/26 Buy

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+3.33%+1.93%-24.39%-42.15% 2.44B
+1.61%+1.35%+47.77%+138.97% 1,258B
-0.61%+5.14%+48.53%+90.05% 679B
+0.09%+2.56%+34.11%+111.64% 518B
+0.17%+2.76%+44.07%+69.71% 390B
-1.03%+1.60%+69.44%+44.97% 367B
+0.76%+2.27%+31.59%+60.36% 307B
-1.29%+0.90%+5.77%+37.60% 293B
-0.31%+0.51%+43.24%+73.43% 252B
+0.38%+1.39%+43.72%+123.66% 210B
Average +0.30%+1.05%+34.38%+70.83% 428B
Weighted average by Cap. +0.21%+1.17%+43.21%+96.21%

Financials

2027 *2028 *
Net sales 14.02B 17.18B 9.6B 8.61B 7.93B 7.21B 13.64B 900B 95.01B 37.85B 482B 36.03B 35.27B 1,525B 14.63B 17.92B 10.02B 8.98B 8.28B 7.52B 14.23B 939B 99.14B 39.5B 503B 37.6B 36.8B 1,591B
Net income 228M 279M 156M 140M 129M 117M 221M 14.61B 1.54B 615M 7.83B 585M 573M 24.75B 263M 323M 180M 162M 149M 135M 256M 16.91B 1.78B 711M 9.06B 677M 662M 28.64B
Net Debt 1.01B 1.24B 695M 623M 574M 521M 987M 65.13B 6.87B 2.74B 34.89B 2.61B 2.55B 110B 976M 1.2B 668M 599M 552M 502M 949M 62.65B 6.61B 2.63B 33.57B 2.51B 2.45B 106B
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
09/11/26 NZ$21.70 +3.33% 138,268
09/11/26 NZ$21.00 -2.05% 77,976
06/11/26 NZ$21.44 -1.11% 84,872
05/11/26 NZ$21.68 +0.93% 106,196
04/11/26 NZ$21.48 +0.14% 232,327
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.64AUD
Average target price
23.04AUD
Spread / Average Target
+30.65%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited